Sarcopenia index significantly linked to subclinical atherosclerosis prevalence in T2DJuly 31, 2022Diabetes
Real-world insights of initiating or switching to insulin degludec/aspart in T2DJuly 31, 2022Diabetes
Initiating semaglutide improves outcomes in patients on high daily doses of insulinJuly 31, 2022Diabetes
Commentary: Benefits of GLP-1 Receptor Agonists and Studies of Continuous Glucose Monitoring, July 2022July 1, 2022Diabetes
